The combination product Xultophy contains both insulin degludec (Tresiba) and liraglutide (a GLP-1) in a single injection
Who Should Not Use GLP-1 Medications According to standard clinical guidelines and prescribing information, GLP-1 medications may not be appropriate for individuals who: Have a personal or family history of medullary thyroid carcinoma Have multiple endocrine neoplasia syndrome type 2 Have a history of pancreatitis Have severe gastrointestinal disease (gastroparesis, inflammatory bowel disease) Are pregnant, planning to become pregnant, or breastfeeding Have a history of severe allergic reactions to semaglutide, tirzepatide, or any inactive ingredients This is not a replacement for prescribed medical treatment for any health condition
Doctronic.ai uses AI to analyze your medications, dosages, and medical history to provide personalized advice on drug interactions, helping you avoid risks and manage your health safely
Fatigue isnt an official side effect of GLP-1 medications, but many people experience temporary tiredness, especially when first starting treatment
Consult physician if pregnant/nursing, taking medication, or have a medical condition (including thyroid disorder)
